跳至主要内容
临床试验/CTRI/2024/04/066177
CTRI/2024/04/066177尚未招募2 期

Efficacy of Sarpagandha ghana vati And Sarpagandha ghana vati Along With Balaguduchyadi Taila Shiropichu In Essential Hypertension A Randomised Controlled Clinical Trial - NI

Manisha0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Criteria for the selection of the patients will
  • be based on the criteria suggested by Joint
  • National Committee 8
  • In patients aged less than 60 years with Systolic
  • Blood Pressure greater than 140 mmHg and
  • Diastolic Blood Pressure greater than 90 mm Hg
  • 2 In patients aged more than 60 years with
  • Systolic Blood Pressure greater than 150mm Hg and
  • Diastolic Blood Pressure greater than 90 mmHg
  • Stages of Grade 1 Hypertension SBP 140 to 159 mm
  • Hg DBP 90 to 99 mmHg
  • 3 Patients between 20 to 70 years age of either
  • 4 Patients fit for snehana karma

排除标准

  • 1 Known cases of Ischemic heart disease Coronary
  • heart disease Coronary artery disease Coarctation
  • 2 Renal failure Endocrine diseases
  • 3 History of cerebral complications like
  • hypertensive encephalopathy cerebral hemorrhage,
  • convulsive seizures
  • 4 Unsatisfactory control of diabetes mellitus or
  • diabetic complications like nephropathy,
  • 5 Malignant hypertension
  • 6 Pregnant and Lactating female patients
  • 7 Patient on treatment for hypertension since 1
  • 8 Patients with scalp disease or infection that
  • hampers the shiropichu procedure

研究者

发起方
Manisha

相似试验